Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T20:37:28.819Z.
Calculation as of: 2026-10-06T20:37:28.819Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ceb9d7bb150905ac81611c4688aa1bd793b2f4eb464ba4dc05e218b0340a6d90
PEG RATIO
N/A
NewcelX Ltd.
Market Cap
$1.33M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| NewcelX Ltd. (NCEL) | $1.33M | N/A |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.34M | N/A |
| Genprex, Inc. (GNPX)vs › | $1.32M | N/A |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.39M | N/A |
| INVO Fertility, Inc. (IVF)vs › | $1.42M | N/A |
| Curis, Inc. (CRIS)vs › | $1.46M | N/A |
| NEXGEL, Inc. (NXGL)vs › | $1.47M | N/A |
| PMGC Holdings Inc. (ELAB)vs › | $1.49M | N/A |
| IM Cannabis Corp. (IMCC)vs › | $1.17M | N/A |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.52M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
